Japanese OK In COPD Gives AstraZeneca’s Breztri Aerosphere First Regulatory Approval

AstraZeneca’s respiratory chief tells Scrip Japan’s approval of the triple-combination inhaled therapy is both a milestone for treating COPD and for the UK pharma’s strategy.